Buscar





Buscar





Mercado
/
Acciones
/
nasdaq-osur
/

OraSure Technologies Inc

OSUR

Añadir a la lista de seguimiento

3.000USD

+0.050+1.69%

Cierre 05/15, 16:00（ET）Cotizaciones retrasadas 15 min

206.55MCap. mercado

PérdidaP/E TTM



OraSure Technologies Inc

3.000

+0.050+1.69%

Descripción general Finanzas Discusiones Análisis Compañía

Descripción general

Finanzas

Discusiones

Análisis

Compañía

Más Datos de OraSure Technologies Inc Compañía

OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

Información de OraSure Technologies Inc



Símbolo de cotizaciónOSUR

Nombre de la empresaOraSure Technologies Inc

Fecha de salida a bolsaNov 17, 1986

Director ejecutivoEglinton Manner (Carrie)

Número de empleados501

Tipo de seguridadOrdinary Share

Fin del año fiscalNov 17

Dirección220 E First St

CiudadBETHLEHEM

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal18015

Teléfono15036416115

Sitio Webhttps://www.orasure.com/

Símbolo de cotizaciónOSUR

Fecha de salida a bolsaNov 17, 1986

Director ejecutivoEglinton Manner (Carrie)

Ejecutivos de OraSure Technologies Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Kenneth J. (Ken) Mcgrath

Chief Financial Officer

589.56K

Mr. John P. Kenny

Independent Chairman of the Board

163.61K

Dr. Nancy J. Gagliano, M.D.

Independent Director

160.25K

Mr. Lelio Marmora

Independent Director

130.76K

Hon Dr. David J. Shulkin, M.D.

Independent Director

126.33K

+52.26%

Ms. Carrie Eglinton Manner

President, Chief Executive Officer, Director

Mr. Jason Plagman

Vice President - Investor Relations

Mr. Robert W. Mcmahon

Independent Director

Ms. Anne Messing

Chief Commercial Officer

Mr. Steven K. (Steve) Boyd

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Kenneth J. (Ken) Mcgrath

Chief Financial Officer

589.56K

Mr. John P. Kenny

Independent Chairman of the Board

163.61K

Dr. Nancy J. Gagliano, M.D.

Independent Director

160.25K

Mr. Lelio Marmora

Independent Director

130.76K

Hon Dr. David J. Shulkin, M.D.

Independent Director

126.33K

+52.26%

Ms. Carrie Eglinton Manner

President, Chief Executive Officer, Director

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Net product and services revenues - HIV

49.80M

43.30%

Net product and services revenues - Microbiome

38.36M

33.35%

Net product and services revenues - HCV

13.76M

11.96%

Other revenues - Other non Product revenues

5.97M

5.19%

Net product and services revenues - Other Products revenue

4.65M

4.04%

Otro

2.49M

2.16%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

78.25M

68.03%

Africa (Region)

23.99M

20.86%

Europe

7.39M

6.43%

Other Regions

5.38M

4.68%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Net product and services revenues - HIV

49.80M

43.30%

Net product and services revenues - Microbiome

38.36M

33.35%

Net product and services revenues - HCV

13.76M

11.96%

Other revenues - Other non Product revenues

5.97M

5.19%

Net product and services revenues - Other Products revenue

4.65M

4.04%

Otro

2.49M

2.16%

Estadísticas de accionistas

Actualizado: dom., 10 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Private Management Group, Inc.

7.88%

BlackRock Institutional Trust Company, N.A.

7.77%

Neuberger Berman, LLC

5.79%

Altai Capital Management, L.P.

5.25%

Vanguard Capital Management, LLC

4.40%

Otro

68.92%

Accionistas

Proporción

Private Management Group, Inc.

7.88%

BlackRock Institutional Trust Company, N.A.

7.77%

Neuberger Berman, LLC

5.79%

Altai Capital Management, L.P.

5.25%

Vanguard Capital Management, LLC

4.40%

Otro

68.92%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

36.78%

Investment Advisor/Hedge Fund

26.42%

Hedge Fund

22.56%

Individual Investor

6.31%

Research Firm

2.55%

Pension Fund

0.44%

Bank and Trust

0.21%

Venture Capital

0.18%

Insurance Company

0.03%

Otro

4.52%

Participación institucional



Actualizado: mié., 1 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

436

65.49M

91.21%

-10.07M

2025Q4

443

65.20M

90.89%

-16.92M

2025Q3

451

66.91M

93.28%

-15.50M

2025Q2

473

72.08M

98.55%

-16.70M

2025Q1

483

70.23M

93.78%

-12.52M

2024Q4

475

70.81M

94.94%

-10.37M

2024Q3

471

70.30M

94.28%

-10.80M

2024Q2

477

73.05M

98.74%

-8.54M

2024Q1

473

74.45M

97.36%

-5.59M

2023Q4

464

73.29M

99.74%

-5.62M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Private Management Group, Inc.

5.40M

7.81%

-21.07K

-0.39%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

5.35M

7.74%

-250.87K

-4.48%

Dec 31, 2025

Neuberger Berman, LLC

3.98M

5.76%

-218.98K

-5.21%

Dec 31, 2025

Altai Capital Management, L.P.

3.61M

5.23%

-127.00K

-3.39%

Mar 17, 2026

Dimensional Fund Advisors, L.P.

3.26M

4.71%

-377.67K

-10.39%

Dec 31, 2025

Systematic Financial Management, L.P.

2.48M

3.58%

-44.87K

-1.78%

Dec 31, 2025

Eglinton (Manner Carrie)

2.19M

3.17%

+360.05K

+19.67%

Mar 20, 2026

Renaissance Technologies LLC

2.15M

3.1%

-116.10K

-5.13%

Dec 31, 2025

Acadian Asset Management LLC

2.02M

2.93%

-102.81K

-4.84%

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Invesco NASDAQ Future Gen 200 ETF

0.44%

iShares US Small Cap Value Factor ETF

0.12%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.05%

iShares Micro-Cap ETF

0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.04%

Avantis US Small Cap Equity ETF

0.02%

WisdomTree US SmallCap Fund

0.02%

ProShares UltraPro Russell2000

0.01%

Proshares Ultra Russell 2000

0.01%

DFA Dimensional US Small Cap Value ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.44%

iShares US Small Cap Value Factor ETF

Proporción0.12%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

Proporción0.05%

iShares Micro-Cap ETF

Proporción0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proporción0.04%

Avantis US Small Cap Equity ETF

Proporción0.02%

WisdomTree US SmallCap Fund

Proporción0.02%

ProShares UltraPro Russell2000

Proporción0.01%

Proshares Ultra Russell 2000

Proporción0.01%

DFA Dimensional US Small Cap Value ETF

Proporción0.01%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

